| 000 | 01788 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513080510.0 | ||
| 264 | 0 | _c19930401 | |
| 008 | 199304s 0 0 eng d | ||
| 022 | _a0882-0139 | ||
| 024 | 7 |
_a10.3109/08820139309066190 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDubinett, S M | |
| 245 | 0 | 0 |
_aInterleukin-2-responsive wound-infiltrating lymphocytes in surgical adjuvant cancer immunotherapy. _h[electronic resource] |
| 260 |
_bImmunological investigations _cFeb 1993 |
||
| 300 |
_a13-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCarcinoma _xpathology |
| 650 | 0 | 4 |
_aCell Adhesion _xdrug effects |
| 650 | 0 | 4 |
_aCytotoxicity, Immunologic _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aImmunologic Factors _xpharmacology |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 | _aInflammation |
| 650 | 0 | 4 |
_aInterleukin-2 _xpharmacology |
| 650 | 0 | 4 |
_aKiller Cells, Lymphokine-Activated _ximmunology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C3H |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aNeoplasm Transplantation |
| 650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
| 650 | 0 | 4 |
_aSarcoma, Experimental _xpathology |
| 650 | 0 | 4 | _aSpecific Pathogen-Free Organisms |
| 650 | 0 | 4 |
_aT-Lymphocyte Subsets _xdrug effects |
| 700 | 1 | _aPatrone, L | |
| 700 | 1 | _aHuang, M | |
| 700 | 1 | _aMarkowitz, J | |
| 700 | 1 | _aMcBride, W H | |
| 700 | 1 | _aEconomou, J S | |
| 700 | 1 | _aTobias, J | |
| 700 | 1 | _aKelley, D | |
| 700 | 1 | _aYan, D | |
| 700 | 1 | _aSeelig, M | |
| 773 | 0 |
_tImmunological investigations _gvol. 22 _gno. 1 _gp. 13-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/08820139309066190 _zAvailable from publisher's website |
| 999 |
_c8439794 _d8439794 |
||